LEJUY yields 39215.69% · JNJ yields 2.13%● Live data
📍 LEJUY pulled ahead of the other in Year 1
Combined, LEJUY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LEJUY + JNJ for your $10,000?
Leju Holdings Limited, through its subsidiaries, provides online to offline (O2O) real estate services in the People's Republic of China. The company offers real estate e-commerce and online advertising services through its online platform, various mobile applications, and Weixin mini programs. Its O2O services for new residential properties include selling discount coupons; facilitating online property viewing, physical property visits, marketing events, and pre-sale customer support; and issuing commission coupons, as well as provides information platform to individual brokers. The company also provides advertisement placement services to advertisers, primarily property developers through online cross-media and cross-platform product portfolio; and brand promotion services to advertisers, including real estate developers and home furnishing suppliers. In addition, it offers Leju Finance, an online platform that provides information and news on the real estate industry, market, and developers featuring their financial performances. The company was incorporated in 2013 and is headquartered in Beijing, the People's Republic of China. Leju Holdings Limited operates as a subsidiary of E-House (China) Enterprise Holdings Limited.
Full LEJUY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.